Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhi-Cheng Lai

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 22, 2022
Reply to J. Mei et alMin-Ke He, Qi-Jiong Li, Zhi-Cheng Lai, et al.
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|December 19, 2024
[Alkaloid compounds in Nelumbinis Folium and their hypolipidemic effect]Jian Jiang, Qian-Nan Xu, Li Che, et al.
Scientific Reports|November 15, 2017
A non-smooth tumor margin on preoperative imaging assesses microvascular invasion of hepatocellular carcinoma: A systematic review and meta-analysisHangTong Hu, Qiao Zheng, Yang Huang, et al.
Life Sciences|June 21, 2018
Do hepatocellular carcinomas located in subcapsular space or in proximity to vessels increase the rate of local tumor progression? A meta-analysisZhi-Cheng Lai, Jin-Yu Liang, Li-Da Chen, et al.
Cell Death & Disease|November 25, 2023
DNA methylation-activated full-length EMX1 facilitates metastasis through EMX1-EGFR-ERK axis in hepatocellular carcinomaDong-Sheng Wen, Li-Chang Huang, Xiao-Yun Bu, et al.
Frontiers in Bioscience (Landmark Edition)|July 31, 2024
TMB Signature-Related RCAN2 Promotes Apoptosis by Upregulating EHF/DR5 Pathway in Hepatocellular CarcinomaYu-Jie Xu, Zhi-Cheng Lai, Anna Kan, et al.
Cancer Immunology, Immunotherapy : CII|April 4, 2021
Comparison of HBV reactivation between patients with high HBV-DNA and low HBV-DNA loads undergoing PD-1 inhibitor and concurrent antiviral prophylaxisMin-Ke He, Chuan Peng, Yang Zhao, et al.
Technology in Cancer Research & Treatment|December 13, 2021
Toripalimab Combined With Hepatic Arterial Infusion Chemotherapy Versus Lenvatinib for Advanced Hepatocellular CarcinomaYu-Jie Xu, Zhi-Cheng Lai, Min-Ke He, et al.
Therapeutic Advances in Medical Oncology|April 15, 2021
Lenvatinib, toripalimab, plus hepatic arterial infusion chemotherapy <i>versus</i> lenvatinib alone for advanced hepatocellular carcinomaMin-Ke He, Run-Bin Liang, Yang Zhao, et al.
Frontiers in Oncology|May 31, 2021
Hepatic Arterial Infusion Chemotherapy of Oxaliplatin, Fluorouracil, and Leucovorin With or Without Sorafenib as Initial Treatment for Advanced Hepatocellular CarcinomaRun-Bin Liang, Yang Zhao, Min-Ke He, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 22, 2022
Reply to J. Mei et alMin-Ke He, Qi-Jiong Li, Zhi-Cheng Lai, et al.
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|December 19, 2024
[Alkaloid compounds in Nelumbinis Folium and their hypolipidemic effect]Jian Jiang, Qian-Nan Xu, Li Che, et al.
Scientific Reports|November 15, 2017
A non-smooth tumor margin on preoperative imaging assesses microvascular invasion of hepatocellular carcinoma: A systematic review and meta-analysisHangTong Hu, Qiao Zheng, Yang Huang, et al.
Life Sciences|June 21, 2018
Do hepatocellular carcinomas located in subcapsular space or in proximity to vessels increase the rate of local tumor progression? A meta-analysisZhi-Cheng Lai, Jin-Yu Liang, Li-Da Chen, et al.
Cell Death & Disease|November 25, 2023
DNA methylation-activated full-length EMX1 facilitates metastasis through EMX1-EGFR-ERK axis in hepatocellular carcinomaDong-Sheng Wen, Li-Chang Huang, Xiao-Yun Bu, et al.
Frontiers in Bioscience (Landmark Edition)|July 31, 2024
TMB Signature-Related RCAN2 Promotes Apoptosis by Upregulating EHF/DR5 Pathway in Hepatocellular CarcinomaYu-Jie Xu, Zhi-Cheng Lai, Anna Kan, et al.
Cancer Immunology, Immunotherapy : CII|April 4, 2021
Comparison of HBV reactivation between patients with high HBV-DNA and low HBV-DNA loads undergoing PD-1 inhibitor and concurrent antiviral prophylaxisMin-Ke He, Chuan Peng, Yang Zhao, et al.
Technology in Cancer Research & Treatment|December 13, 2021
Toripalimab Combined With Hepatic Arterial Infusion Chemotherapy Versus Lenvatinib for Advanced Hepatocellular CarcinomaYu-Jie Xu, Zhi-Cheng Lai, Min-Ke He, et al.
Therapeutic Advances in Medical Oncology|April 15, 2021
Lenvatinib, toripalimab, plus hepatic arterial infusion chemotherapy <i>versus</i> lenvatinib alone for advanced hepatocellular carcinomaMin-Ke He, Run-Bin Liang, Yang Zhao, et al.
Frontiers in Oncology|May 31, 2021
Hepatic Arterial Infusion Chemotherapy of Oxaliplatin, Fluorouracil, and Leucovorin With or Without Sorafenib as Initial Treatment for Advanced Hepatocellular CarcinomaRun-Bin Liang, Yang Zhao, Min-Ke He, et al.
Pageof 1